{"symbol":"PFE","fiscalQuarter":"Q1-2020","reportDate":"2020-04-28","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q1-2020","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 1.1%","keyNumbers":[{"metric":"EPS","actual":"$0.80","expected":"N/A","surprise":"+12.68%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are focused on continuing our research and development efforts.","Our pipeline remains strong despite current challenges."],"summary":"Management expressed confidence in their ongoing projects and emphasized the importance of their research initiatives. They acknowledged the challenges posed by the current environment but remained optimistic about future developments."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.1%, likely due to a lack of revenue information and no guidance updates. Investors may be cautious as the company navigates ongoing challenges in the market.","metaDescription":"Pfizer Inc (PFE) Q1 2020 earnings: EPS beat by 12.68%. Stock down 1.1%. Full breakdown."}}